Last updated on April 2019

SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis.


Brief description of study

A Phase 3, randomized, double-masked, vehicle-controlled trial to evaluate the safety and efficacy of ADX-102 ophthalmic solution in Subjects with non-infectious anterior-uveitis.

Clinical Study Identifier: NCT03131154

Find a site near you

Start Over

Retinal Research Institute

Phoenix, AZ United States
  Connect »

UAB Department of Ophthalmology

Birmingham, AL United States
  Connect »

M&M Eye Institute

Prescott, AZ United States
  Connect »

Walman Eye Center

Sun City, AZ United States
  Connect »

Levenson Eye Associates

Jacksonville, FL United States
  Connect »

Midwest Eye Institute

Indianapolis, IN United States
  Connect »

John Hopkins

Baltimore, MD United States
  Connect »

Oakland Ophthalmic Surgery

Birmingham, MI United States
  Connect »

Tauber Eye Center

Kansas City, MO United States
  Connect »

Bergstrom Eye Research

Fargo, ND United States
  Connect »

Oregon Retina, LLP

Eugene, OR United States
  Connect »

Texas Retina Associates

Dallas, TX United States
  Connect »

Retina Consultants of Houston

The Woodlands, TX United States
  Connect »

Virginia Eye Consultants

Norfolk, VA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.